✦ LIBER ✦

Cost-effectiveness of anastrozole vs tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer: a UK national health service perspective

✍ Scribed by R.E Mansel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost utility analysis of early adjuvant

✍ Jonathan Karnon; Thomas Delea; Vicki Barghout 📂 Article 📅 2007 🏛 Springer 🌐 French ⚖ 297 KB

P181 Cost-effectiveness analysis of letr

✍ J. Karnon; M. Berli`ere; H. Depypere; L. Dirix; G. Jerusalem; P. Neven; R. Parid 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Pharmacoeconomic aspects of adjuvant ear

✍ P Piskur; M Sonc; T Cufer; S Borstnar; A Mrhar 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Cost-effectiveness of letrozole versus t

✍ Thomas E. Delea; Khalid El-Ouagari; Jonathan Karnon; Oleg Sofrygin 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 301 KB

Anastrozole is cost-effective vs tamoxif

✍ A. Rocchi; S. Verma 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 158 KB

PCN6 A COST-EFFECTIVENESS ANALYSIS OF AD

✍ J Mould-Quevedo; J Tapia-Valencia; G Davila-Loaiza 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB